These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 35564639)

  • 21. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 22. "Intention to receive COVID-19 vaccine among healthcare workers: a comparison between two surveys".
    Meysamie A; Ghasemi E; Moshksar S; Askarian M
    BMC Health Serv Res; 2022 Aug; 22(1):982. PubMed ID: 35915483
    [TBL] [Abstract][Full Text] [Related]  

  • 23. COVID-19 vaccine booster dose hesitancy among key groups: A cross-sectional study.
    Huang M; He R; Chen Q; Song J; Huang H; Zheng S
    Hum Vaccin Immunother; 2023 Dec; 19(1):2166323. PubMed ID: 36951564
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Psychological Experience of COVID-19 Vaccination and Its Impact on the Willingness to Receive Booster Vaccines among the Chinese Population: Evidence from a National Cross-Sectional Study.
    Miao Y; Li Y; Zhang W; Wu J; Gu J; Wang M; Wei W; Ye B; Miao C; Tarimo CS; Dong W
    Int J Environ Res Public Health; 2022 Apr; 19(9):. PubMed ID: 35564859
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Willingness-to-pay for a booster dose of inactivated SARS-CoV-2 vaccine in Taizhou, China.
    Tung TH; Lin XQ; Chen Y; Zhang MX; Zhu JS
    Hum Vaccin Immunother; 2022 Nov; 18(6):2099210. PubMed ID: 35880816
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vaccination coverage among COVID-19 prevention and control management teams at primary healthcare facilities in China and their attitudes towards COVID-19 vaccine: a cross-sectional online survey.
    Yan YY; Wang HT; Fan TY; Sun XJ; Du ZH; Sun XM
    BMJ Open; 2022 Apr; 12(4):e056345. PubMed ID: 35393315
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effectiveness of a COVID-19 Additional Primary or Booster Vaccine Dose in Preventing SARS-CoV-2 Infection Among Nursing Home Residents During Widespread Circulation of the Omicron Variant - United States, February 14-March 27, 2022.
    Prasad N; Derado G; Nanduri SA; Reses HE; Dubendris H; Wong E; Soe MM; Li Q; Dollard P; Bagchi S; Edwards J; Shang N; Budnitz D; Bell J; Verani JR; Benin A; Link-Gelles R; Jernigan J; Pilishvili T
    MMWR Morb Mortal Wkly Rep; 2022 May; 71(18):633-637. PubMed ID: 35511708
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effectiveness of homologous and heterologous booster doses for an inactivated SARS-CoV-2 vaccine: a large-scale prospective cohort study.
    Jara A; Undurraga EA; Zubizarreta JR; González C; Pizarro A; Acevedo J; Leo K; Paredes F; Bralic T; Vergara V; Mosso M; Leon F; Parot I; Leighton P; Suárez P; Rios JC; García-Escorza H; Araos R
    Lancet Glob Health; 2022 Jun; 10(6):e798-e806. PubMed ID: 35472300
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Post-vaccination adverse reactions, decision regret, and willingness to pay for the booster dose of COVID-19 vaccine among healthcare workers: A mediation analysis.
    Luo C; Jiang W; Chen HX; Tung TH
    Hum Vaccin Immunother; 2022 Nov; 18(6):2146964. PubMed ID: 36422511
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Resilience and intention of healthcare workers in China to receive a COVID-19 vaccination: The mediating role of life satisfaction and stigma.
    Mo PKH; She R; Yu Y; Li L; Yang Q; Lin J; Ye X; Wu S; Yang Z; Guan S; Zhang J; Hu H; Xie L; Lau JTF
    J Adv Nurs; 2022 Aug; 78(8):2327-2338. PubMed ID: 35195300
    [TBL] [Abstract][Full Text] [Related]  

  • 31. COVID-19 vaccine coverage, safety, and perceptions among patients with diabetes mellitus in China: a cross-sectional study.
    Li H; Ping F; Li X; Wang Z; Xiao J; Jiang H; Xue Y; Quan J; Yao H; Zheng X; Chen Y; Li Y; Yu X; Xu L; Feng X; Wang S; Li Y; Xiao X
    Front Endocrinol (Lausanne); 2023; 14():1172089. PubMed ID: 37334292
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multi-dimensional psychosocial factors influencing the willingness to receive a COVID-19 vaccine booster: A survey among the public in Mainland China.
    Lin Y; Huang Z; Xu X; Du W; Alias H; Hu Z; Wong LP
    Hum Vaccin Immunother; 2022 Nov; 18(6):2126667. PubMed ID: 36165498
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Parental acceptability of COVID-19 vaccination for children under the age of 18 years among Chinese doctors and nurses: a cross-sectional online survey.
    Wang Z; She R; Chen X; Li L; Li L; Huang Z; Lau JTF
    Hum Vaccin Immunother; 2021 Oct; 17(10):3322-3332. PubMed ID: 34137670
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Willingness toward COVID-19 vaccination, coadministration with other vaccines and receive a COVID-19 vaccine booster: a cross-sectional study on the guardians of children in China.
    Ma L; Yang J; Zhang T; Han X; Huang Q; Yang Y; Feng L; Yang W; Wang C
    Hum Vaccin Immunother; 2022 Nov; 18(5):2049169. PubMed ID: 35417663
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The intention to get COVID-19 booster vaccination and its association with cognitive and emotional factors: A survey of Chinese COVID-19 infected people in Hong Kong.
    Yu Y; Zhang X; Lau MMC; Lau JTF
    Vaccine; 2024 Jan; 42(2):206-212. PubMed ID: 38065769
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effectiveness of Homologous and Heterologous COVID-19 Booster Doses Following 1 Ad.26.COV2.S (Janssen [Johnson & Johnson]) Vaccine Dose Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults - VISION Network, 10 States, December 2021-March 2022.
    Natarajan K; Prasad N; Dascomb K; Irving SA; Yang DH; Gaglani M; Klein NP; DeSilva MB; Ong TC; Grannis SJ; Stenehjem E; Link-Gelles R; Rowley EA; Naleway AL; Han J; Raiyani C; Benitez GV; Rao S; Lewis N; Fadel WF; Grisel N; Griggs EP; Dunne MM; Stockwell MS; Mamawala M; McEvoy C; Barron MA; Goddard K; Valvi NR; Arndorfer J; Patel P; Mitchell PK; Smith M; Kharbanda AB; Fireman B; Embi PJ; Dickerson M; Davis JM; Zerbo O; Dalton AF; Wondimu MH; Azziz-Baumgartner E; Bozio CH; Reynolds S; Ferdinands J; Williams J; Schrag SJ; Verani JR; Ball S; Thompson MG; Dixon BE
    MMWR Morb Mortal Wkly Rep; 2022 Apr; 71(13):495-502. PubMed ID: 35358170
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The association between adverse events of COVID-19 vaccination and anxiety and willingness to receive a booster dose.
    Chen L; Liang H; Liu L; Qiu W; Su L; Yang H
    Hum Vaccin Immunother; 2023 Dec; 19(1):2176643. PubMed ID: 36798968
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Trends in primary, booster, and updated COVID-19 vaccine readiness in the United States, January 2021-April 2023: Implications for 2023-2024 updated COVID-19 vaccines.
    Ihongbe TO; Kim JC; Dahlen H; Kranzler EC; Seserman K; Moffett K; Hoffman L
    Prev Med; 2024 Mar; 180():107887. PubMed ID: 38325608
    [TBL] [Abstract][Full Text] [Related]  

  • 39. COVID-19 booster vaccine willingness.
    Sønderskov KM; Vistisen HT; Dinesen PT; Østergaard SD
    Dan Med J; 2021 Dec; 69(1):. PubMed ID: 34913428
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Willingness to receive the second booster of COVID-19 vaccine among older adults with cancer: a stratified analysis in four provinces of China.
    Zhang L; Yang J; Su R; Lan X; Song M; Zhang L; Xu J
    Front Public Health; 2024; 12():1298070. PubMed ID: 38454989
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.